<?xml version="1.0" encoding="UTF-8"?>
<ref id="B172-vaccines-08-00036">
 <label>172.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>He</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Manischewitz</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Meseda</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Merchlinsky</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Vassell</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Sirota</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Berkower</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Golding</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Weiss</surname>
    <given-names>C.D.</given-names>
   </name>
  </person-group>
  <article-title>Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity</article-title>
  <source>J. Infect. Dis.</source>
  <year>2007</year>
  <volume>196</volume>
  <fpage>1026</fpage>
  <lpage>1032</lpage>
  <pub-id pub-id-type="doi">10.1086/520936</pub-id>
  <pub-id pub-id-type="pmid">17763325</pub-id>
 </element-citation>
</ref>
